Clinical TrialsSearch results
Number of results: 341
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Research on the usefulness of pneumococcal polysaccharide vaccine for elderly in the nursing home
- Pneumonia in the nursing home
- Research Institute for Microbial Diseases, Osaka University
- 2009-07-17
Other
- Relationship between the response to CPT-11/platimun regimen and BCRP DNA Metylation in patients with NSCLC recurrence after surgical resection.
- NSCLC
- Nagasaki Thoracic Oncology Group
- 2012-12-31
Other
- Registry of Japanese Rheumatoid Arthritis Patients on Biologics for Long-term Safety (REAL)
- rheumatoid arthritis
- Department of Pharmacovigilance, Tokyo Medical and Dental University
- 2008-08-01
Other
- Registration Program for Myelodysplastic Syndromes and Aplastic Anemia
- Myelodysplastic Syndromes Aplastic Anemia
- Keio University School of Medicine
- 2007-04-28
Other
- RCC-SNPs Ensuring-study for Leading Eligibility of patients in Cytokine Therapy
- Renal cell carcinoma
- JISG-KC
- 2007-06-04
Other
- Randomized, double-blind, placebo-controlled study of AMG0001(HGF plasmid) for patients with arteriosclerosis obliterans
- Arteriosclerosis obliterans
- Anges MG, Inc.
- 2007-06-04
Other
- Randomized Study to Assess the Efficacy of a Further 5 Years of Anastrozole Treatment for Postmenopausal Women with Breast Cancer Completing 5 Years Anastrozole Containing Adjuvant Endocrine Therapy
- Hormone-responsive postmenopausal primary breast cancer
- AERAS executive committee
- 2007-09-05
Other
- Randomized study of Taxane vs TS-1 in metastatic or recurrent breast cancer patients
- Metastatic or recurrent breast cancer
- SELECT BC executive committee
- 2006-06-01
Other
- randomized study of Gemicitabine alone or UFT adjuvant chemotherapy for stage IB-IIIA non small cell lung cancer after complete resection
- stage IB-IIIA non small cell lung cancer after complete resection
- West Japan Oncology Group
- 2005-09-06
Other
- Randomized study comparing six times of epirubicin instillation for 2.5 months with six times for two weeks in superficial bladder cancer after transurethral resection of bladder tumor
- Superficial bladder cancer
- Japanese Urological Cancer Research Group
- 2005-09-30